Edward T Mathers's Net Worth

$130 Million

Who is Edward T Mathers?

Edward T Mathers has an estimated net worth of $130 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., Bright Health Group Inc., Monte Rosa Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Reneo Pharmaceuticals, Inc., Inozyme Pharma, Inc., Savara Inc, Trevi Therapeutics, Inc., SYNLOGIC, INC., Akouos, Inc., Ra Pharmaceuticals, Inc., Senti Biosciences, Inc., ObsEva SA, Liquidia Technologies Inc, MEDIMMUNE INC /DE, and Korro Bio, Inc..

SEC CIK

Edward T Mathers's CIK is 0001328625

Past Insider Trading and Trends

2021 was Edward T Mathers's most active year for acquiring shares with 12 total transactions. Edward T Mathers's most active month to acquire stocks was the month of May. 2007 was Edward T Mathers's most active year for disposing of shares, totalling 7 transactions. Edward T Mathers's most active month to dispose stocks was the month of May. 2022 saw Edward T Mathers paying a total of $145,200,001.20 for 4,338,515 shares, this is the most they've acquired in one year. In 2006 Edward T Mathers cashed out on 80,000 shares for a total of $1,303,420.00, their largest year based on trade value.